GLP-1 Receptor Agonist
Compounded Semaglutide
Semaglutide is a weekly injectable GLP-1 receptor agonist that works by mimicking the GLP-1 hormone to reduce appetite, slow gastric emptying, and improve blood sugar regulation. It is one of the most studied and widely used medications in medical weight loss. Our compounded semaglutide is prepared by a licensed compound pharmacy and dosed according to your personalized protocol.
- Weekly self-injection
- Reduces appetite and cravings
- Slows gastric emptying
- Improves insulin sensitivity
- Customized dosing protocol
Dual GIP/GLP-1 Agonist
Compounded Tirzepatide
Tirzepatide is a dual-agonist that targets both the GIP and GLP-1 hormonal pathways simultaneously, and in clinical studies of the FDA-approved form it produced strong weight loss results. By activating two pathways instead of one, it is designed to provide greater appetite and metabolic support. Our compounded tirzepatide is sourced from a licensed, accredited compound pharmacy and prescribed based on your individual health profile.
- Weekly self-injection
- Dual GIP and GLP-1 action
- Two-pathway appetite support
- Metabolic support
- Customized dosing protocol